Hiro‐omi Kanayama - Concepedia

Author

Hiro‐omi Kanayama

Also Known As

H Kanayama, H O Kanayama, H. Kanayama, H.-o. Kanayama, HIRO-OMI KANAYAMA, HIROOMI KANAYAMA, HIRO‐OMI KANAYAMA, Hiro-Omi Kanayama, Hiro-omi KANAYAMA, Hiro-omi Kanayama

332

Publications

6.2K

Citations

H-Index

122

Concepts

All Affiliations

Tokushima University Kyushu University The University of Tokyo Hokkaido University Kyoto Prefectural University of Medicine

About

Hiro‐omi Kanayama is an author at Tokushima University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	43	2.8K
2	Biochemistry	5	5	184
3	Natural Sciences	4	4	217
4	Health Sciences	3	3	78
5	Public Health	1	1	28

Hiro‐omi Kanayama

113

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, The Lancet Oncology First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine	2021	627
Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification Masayuki Takahashi, Daniel R. Rhodes, Kyle A. Furge, Proceedings of the National Academy of Sciences Ccrcc TumorsPathologyGene Expression ProfilingTumor BiologyGenitourinary Cancer	2001	403
Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer Hiro‐omi Kanayama, Kinya Yokota, Yasushi Kurokawa, Cancer	1998	190
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers Masayuki Takahashi, Ximing J. Yang, Jun Sugimura, Oncogene Tumor BiologyKidney TumorsUrologyMolecular SubclassificationNew Diagnostic Markers	2003	182
Role of the vitamin D receptor in FGF23 action on phosphate metabolism Yoshio Inoue, Hiroko Segawa, Ichiro Kaneko, Biochemical Journal	2005	166
Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Hiro‐omi Kanayama, Keiji Tanaka, Masashi Aki, PubMed ProteasomePathologyProteasome SynthesisCancer BiologyTumor Biology	1991	165
Current Status of Endoscopic Surgery in <scp>Japan</scp>: The 15th <scp>National Survey of Endoscopic Surgery</scp> by the <scp>Japan Society for Endoscopic Surgery</scp> Hidefumi Shiroshita, Masafumi Inomata, Shigeo Akira, Asian Journal of Endoscopic Surgery LaparoscopyGastroenterologySurgical ScienceSurgeryUpper Gastrointestinal Surgery	2021	126
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell Carcinoma Yoshihiko Tomita, Hirotsugu Uemura, Hiroyuki Fujimoto, European Journal of Cancer UrologyRenal FunctionGenitourinary CancerMedicinePathology	2011	123
Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin‐ligated proteins by closely linked mechanisms Hiro‐omi Kanayama, Tomohiro Tamura, Shin‐ichi Ugai, European Journal of Biochemistry	1992	122
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas Jindong Chen, Weng‐Onn Lui, Michele D. Vos, Cancer Cell Genitourinary CancerCancer GenomicsTumor SuppressorCancer GeneticsSystems Biology	2003	116

Page 1